147 related articles for article (PubMed ID: 10099057)
1. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
Gorter RW; van Wely M; Stoss M; Wollina U
Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
[TBL] [Abstract][Full Text] [Related]
2. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
4. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Kelter G; Fiebig HH
Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
[TBL] [Abstract][Full Text] [Related]
5. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
6. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
[TBL] [Abstract][Full Text] [Related]
8. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Maier G; Fiebig HH
Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
[TBL] [Abstract][Full Text] [Related]
9. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
[TBL] [Abstract][Full Text] [Related]
10. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
Stein G; Berg PA
Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
[TBL] [Abstract][Full Text] [Related]
11. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
[TBL] [Abstract][Full Text] [Related]
12. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.
van Wely M; Stoss M; Gorter RW
Am J Ther; 1999 Jan; 6(1):37-43. PubMed ID: 10423645
[TBL] [Abstract][Full Text] [Related]
14. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
Glardon ; Pache ; Magnenat ; Pin ; Parvis
Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
[TBL] [Abstract][Full Text] [Related]
15. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
Hajto T; Hostanska K; Gabius HJ
Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of iscador: a Viscum album preparation.
Hajto T
Oncology; 1986; 43 Suppl 1():51-65. PubMed ID: 2433654
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and clinical effects of Viscum album (Iscador M and Iscador P) in children with recurrent respiratory infections as a result of the Chernobyl nuclear accident.
Chernyshov VP; Heusser P; Omelchenko LI; Chernyshova LI; Vodyanik MA; Vykhovanets EV; Galazyuk LV; Pochinok TV; Gaiday NV; Gumenyuk ME; Zelinsky GM; Schaefermeyer H; Schaefermeyer G
Am J Ther; 2000 May; 7(3):195-203. PubMed ID: 11317168
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
[TBL] [Abstract][Full Text] [Related]
19. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
20. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
